Up Next
Back to Show
PBS News Hour
Why FDA approval of sickle cell gene therapy is a ‘big deal’
Sickle cell disease is a chronic, debilitating condition that affects nearly 100,000 Americans, most of them with African ancestry. Now, the FDA has approved a groundbreaking treatment for it that uses the gene-editing tool CRISPR. John Yang speaks with Yale School of Medicine assistant professor Dr. Cece Calhoun and New York Times reporter Gina Kolata to learn more.
Support Provided By
57:46
October 24, 2025 - PBS News Hour full episode
56:42
October 23, 2025 - PBS News Hour full episode
57:46
October 22, 2025 - PBS News Hour full episode
57:46
October 21, 2025 - PBS News Hour full episode
57:46
October 20, 2025 - PBS News Hour full episode
26:44
October 19, 2025 - PBS News Weekend full episode
26:44
October 18, 2025 - PBS News Weekend full episode
57:46
October 17, 2025 - PBS News Hour full episode
57:46
October 16, 2025 - PBS News Hour full episode
57:46
October 15, 2025 - PBS News Hour full episode
57:46
October 14, 2025 - PBS News Hour full episode
57:46
October 13, 2025 - PBS News Hour full episode